MKK4 showed consistent results in inhibiting lipid metabolism disorders by reducing serum TC, TG, and LDL-C and raising HDL-C levels in mice/rats [27,28,29,30]. The gene discussed is MAP2K4; the disease is Disorder of lipid metabolism.